

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | behavioral response to nicotine (GO:0035095) | 5.00086719 |
| 2 | cell proliferation in forebrain (GO:0021846) | 4.55294944 |
| 3 | otic vesicle formation (GO:0030916) | 4.23277549 |
| 4 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.22543901 |
| 5 | pharyngeal system development (GO:0060037) | 4.03090065 |
| 6 | negative regulation of mast cell activation (GO:0033004) | 3.88850380 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 3.80821481 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 3.80821481 |
| 9 | tryptophan catabolic process (GO:0006569) | 3.80821481 |
| 10 | sulfation (GO:0051923) | 3.79999016 |
| 11 | DNA deamination (GO:0045006) | 3.79057752 |
| 12 | indolalkylamine metabolic process (GO:0006586) | 3.78982891 |
| 13 | kynurenine metabolic process (GO:0070189) | 3.73726731 |
| 14 | regulation of acrosome reaction (GO:0060046) | 3.55358839 |
| 15 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.55343894 |
| 16 | fucose catabolic process (GO:0019317) | 3.43854135 |
| 17 | L-fucose metabolic process (GO:0042354) | 3.43854135 |
| 18 | L-fucose catabolic process (GO:0042355) | 3.43854135 |
| 19 | histone H4-K12 acetylation (GO:0043983) | 3.41246285 |
| 20 | prostate gland growth (GO:0060736) | 3.31698955 |
| 21 | forebrain morphogenesis (GO:0048853) | 3.29408776 |
| 22 | seminiferous tubule development (GO:0072520) | 3.29205319 |
| 23 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.26096974 |
| 24 | tryptophan metabolic process (GO:0006568) | 3.23330070 |
| 25 | somite development (GO:0061053) | 3.19429781 |
| 26 | cobalamin metabolic process (GO:0009235) | 3.17989509 |
| 27 | parturition (GO:0007567) | 3.16080349 |
| 28 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.10955315 |
| 29 | detection of light stimulus involved in visual perception (GO:0050908) | 3.10955315 |
| 30 | gamma-aminobutyric acid transport (GO:0015812) | 3.09312104 |
| 31 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.06884643 |
| 32 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.01706188 |
| 33 | regulation of collateral sprouting (GO:0048670) | 3.01604933 |
| 34 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.97057295 |
| 35 | indole-containing compound metabolic process (GO:0042430) | 2.96722969 |
| 36 | neural tube formation (GO:0001841) | 2.94941985 |
| 37 | glycerophospholipid catabolic process (GO:0046475) | 2.92139645 |
| 38 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.91457736 |
| 39 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.91457736 |
| 40 | neuronal action potential (GO:0019228) | 2.91150391 |
| 41 | regulation of action potential (GO:0098900) | 2.89209946 |
| 42 | negative regulation of epidermal cell differentiation (GO:0045605) | 2.85842986 |
| 43 | cellular response to ATP (GO:0071318) | 2.85319142 |
| 44 | adaptation of signaling pathway (GO:0023058) | 2.84897027 |
| 45 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.83778309 |
| 46 | replication fork processing (GO:0031297) | 2.83042592 |
| 47 | protein polyglutamylation (GO:0018095) | 2.82343187 |
| 48 | regulation of telomere maintenance (GO:0032204) | 2.81960050 |
| 49 | negative regulation of astrocyte differentiation (GO:0048712) | 2.81476014 |
| 50 | serotonin metabolic process (GO:0042428) | 2.80839058 |
| 51 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 2.80246504 |
| 52 | negative regulation of dendrite development (GO:2000171) | 2.79519965 |
| 53 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.78301273 |
| 54 | regulation of hippo signaling (GO:0035330) | 2.75008244 |
| 55 | lung morphogenesis (GO:0060425) | 2.74112658 |
| 56 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.72740374 |
| 57 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.70442156 |
| 58 | regulation of mesoderm development (GO:2000380) | 2.67367781 |
| 59 | primary amino compound metabolic process (GO:1901160) | 2.66242740 |
| 60 | negative regulation of appetite (GO:0032099) | 2.63765821 |
| 61 | negative regulation of response to food (GO:0032096) | 2.63765821 |
| 62 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.60163423 |
| 63 | regulation of cardioblast proliferation (GO:0003264) | 2.59783469 |
| 64 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 2.59783469 |
| 65 | kidney morphogenesis (GO:0060993) | 2.57057657 |
| 66 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 2.56829828 |
| 67 | axoneme assembly (GO:0035082) | 2.56435274 |
| 68 | cellular biogenic amine catabolic process (GO:0042402) | 2.56302223 |
| 69 | amine catabolic process (GO:0009310) | 2.56302223 |
| 70 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.52268934 |
| 71 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.51584251 |
| 72 | photoreceptor cell development (GO:0042461) | 2.50421582 |
| 73 | platelet dense granule organization (GO:0060155) | 2.47683024 |
| 74 | response to pheromone (GO:0019236) | 2.46243597 |
| 75 | piRNA metabolic process (GO:0034587) | 2.45673521 |
| 76 | embryonic epithelial tube formation (GO:0001838) | 2.44187552 |
| 77 | action potential (GO:0001508) | 2.44051940 |
| 78 | positive regulation of defense response to virus by host (GO:0002230) | 2.42653094 |
| 79 | multicellular organism reproduction (GO:0032504) | 2.40880938 |
| 80 | interkinetic nuclear migration (GO:0022027) | 2.40605483 |
| 81 | positive regulation of fatty acid transport (GO:2000193) | 2.40414359 |
| 82 | behavioral response to ethanol (GO:0048149) | 2.36968287 |
| 83 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.36716487 |
| 84 | regulation of sequestering of triglyceride (GO:0010889) | 2.35752609 |
| 85 | cellular response to exogenous dsRNA (GO:0071360) | 2.35739705 |
| 86 | eye photoreceptor cell development (GO:0042462) | 2.35131450 |
| 87 | negative regulation of protein oligomerization (GO:0032460) | 2.34513670 |
| 88 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.34031337 |
| 89 | positive regulation of fatty acid oxidation (GO:0046321) | 2.33634211 |
| 90 | thyroid gland development (GO:0030878) | 2.32805291 |
| 91 | transmission of nerve impulse (GO:0019226) | 2.32191622 |
| 92 | membrane depolarization during action potential (GO:0086010) | 2.32098758 |
| 93 | reflex (GO:0060004) | 2.32082846 |
| 94 | regulation of germinal center formation (GO:0002634) | 2.32018197 |
| 95 | GPI anchor metabolic process (GO:0006505) | 2.31938755 |
| 96 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.31620038 |
| 97 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.30249134 |
| 98 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.30192329 |
| 99 | benzene-containing compound metabolic process (GO:0042537) | 2.29722523 |
| 100 | aorta morphogenesis (GO:0035909) | 2.27949105 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.94485260 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.23941422 |
| 3 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.97173391 |
| 4 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.60578275 |
| 5 | VDR_22108803_ChIP-Seq_LS180_Human | 2.53998757 |
| 6 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.35782209 |
| 7 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.31926436 |
| 8 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.18311907 |
| 9 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.16075389 |
| 10 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.11636367 |
| 11 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.08478568 |
| 12 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.04656722 |
| 13 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.03002007 |
| 14 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.96613791 |
| 15 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.94466213 |
| 16 | FUS_26573619_Chip-Seq_HEK293_Human | 1.94125038 |
| 17 | P300_19829295_ChIP-Seq_ESCs_Human | 1.92748783 |
| 18 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.85049480 |
| 19 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.83891563 |
| 20 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.82783589 |
| 21 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.78868758 |
| 22 | EWS_26573619_Chip-Seq_HEK293_Human | 1.78374648 |
| 23 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.66718868 |
| 24 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.64540249 |
| 25 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.63420134 |
| 26 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.60459634 |
| 27 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.59352998 |
| 28 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.58307825 |
| 29 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.55205028 |
| 30 | STAT3_23295773_ChIP-Seq_U87_Human | 1.53194562 |
| 31 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.50894098 |
| 32 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.50154517 |
| 33 | TCF4_23295773_ChIP-Seq_U87_Human | 1.49315547 |
| 34 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.48532128 |
| 35 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.46733415 |
| 36 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.45508061 |
| 37 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.44794975 |
| 38 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.44671688 |
| 39 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.44671688 |
| 40 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.42951676 |
| 41 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.39253594 |
| 42 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.37501897 |
| 43 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.37292040 |
| 44 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.36269214 |
| 45 | AR_25329375_ChIP-Seq_VCAP_Human | 1.35695157 |
| 46 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.33925343 |
| 47 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.33686690 |
| 48 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.32727284 |
| 49 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.31461146 |
| 50 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.31308395 |
| 51 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.30335899 |
| 52 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.27923870 |
| 53 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.27147378 |
| 54 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.26137015 |
| 55 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.25036507 |
| 56 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.23941291 |
| 57 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.23801697 |
| 58 | * IRF1_19129219_ChIP-ChIP_H3396_Human | 1.23690023 |
| 59 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.23218349 |
| 60 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.22948636 |
| 61 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.21958213 |
| 62 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.21881056 |
| 63 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.21817497 |
| 64 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.21327595 |
| 65 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.20896435 |
| 66 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.18024424 |
| 67 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.17674646 |
| 68 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.15544994 |
| 69 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.15386043 |
| 70 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14671545 |
| 71 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.14671545 |
| 72 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14514245 |
| 73 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.14086381 |
| 74 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.14046217 |
| 75 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.13379254 |
| 76 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.13379254 |
| 77 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.13043591 |
| 78 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.12840189 |
| 79 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.12654768 |
| 80 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.10869004 |
| 81 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.10406547 |
| 82 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.10277070 |
| 83 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.10174654 |
| 84 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.09954881 |
| 85 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.09954881 |
| 86 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.07535464 |
| 87 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.07439763 |
| 88 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.06613140 |
| 89 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.06270059 |
| 90 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.06197124 |
| 91 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.05803904 |
| 92 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.05778446 |
| 93 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05110862 |
| 94 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.02507200 |
| 95 | KDM2B_26808549_Chip-Seq_REH_Human | 1.01988613 |
| 96 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.01134543 |
| 97 | NCOR_22424771_ChIP-Seq_293T_Human | 1.01100912 |
| 98 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.99000411 |
| 99 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.97986957 |
| 100 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.97731222 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 4.02414770 |
| 2 | MP0003646_muscle_fatigue | 4.01735460 |
| 3 | MP0003787_abnormal_imprinting | 3.62776180 |
| 4 | MP0006292_abnormal_olfactory_placode | 3.20750235 |
| 5 | MP0005646_abnormal_pituitary_gland | 3.17536826 |
| 6 | MP0003195_calcinosis | 2.47567832 |
| 7 | MP0004885_abnormal_endolymph | 2.33680395 |
| 8 | MP0002102_abnormal_ear_morphology | 2.31210290 |
| 9 | MP0002138_abnormal_hepatobiliary_system | 2.27013243 |
| 10 | MP0005551_abnormal_eye_electrophysiolog | 2.18163567 |
| 11 | MP0008877_abnormal_DNA_methylation | 2.01813120 |
| 12 | MP0002876_abnormal_thyroid_physiology | 2.00064166 |
| 13 | MP0001968_abnormal_touch/_nociception | 1.97591576 |
| 14 | MP0000678_abnormal_parathyroid_gland | 1.97080033 |
| 15 | MP0000631_abnormal_neuroendocrine_gland | 1.89637360 |
| 16 | MP0005389_reproductive_system_phenotype | 1.88406829 |
| 17 | MP0009745_abnormal_behavioral_response | 1.85072389 |
| 18 | MP0000569_abnormal_digit_pigmentation | 1.84726041 |
| 19 | MP0001501_abnormal_sleep_pattern | 1.74595140 |
| 20 | MP0002160_abnormal_reproductive_system | 1.73896116 |
| 21 | MP0004130_abnormal_muscle_cell | 1.69013245 |
| 22 | MP0003724_increased_susceptibility_to | 1.68101874 |
| 23 | MP0001485_abnormal_pinna_reflex | 1.68075407 |
| 24 | MP0008872_abnormal_physiological_respon | 1.61330742 |
| 25 | MP0002272_abnormal_nervous_system | 1.58512659 |
| 26 | MP0004142_abnormal_muscle_tone | 1.55772960 |
| 27 | MP0001486_abnormal_startle_reflex | 1.52682780 |
| 28 | MP0000049_abnormal_middle_ear | 1.51235511 |
| 29 | MP0001986_abnormal_taste_sensitivity | 1.48735754 |
| 30 | MP0009046_muscle_twitch | 1.48286475 |
| 31 | MP0006072_abnormal_retinal_apoptosis | 1.44764410 |
| 32 | MP0001919_abnormal_reproductive_system | 1.43624691 |
| 33 | MP0005645_abnormal_hypothalamus_physiol | 1.40487840 |
| 34 | MP0002064_seizures | 1.39994832 |
| 35 | MP0003938_abnormal_ear_development | 1.39097451 |
| 36 | MP0005253_abnormal_eye_physiology | 1.32271312 |
| 37 | MP0004145_abnormal_muscle_electrophysio | 1.31471081 |
| 38 | MP0002735_abnormal_chemical_nociception | 1.29968976 |
| 39 | MP0002736_abnormal_nociception_after | 1.29714299 |
| 40 | MP0005084_abnormal_gallbladder_morpholo | 1.29493053 |
| 41 | MP0003283_abnormal_digestive_organ | 1.24310556 |
| 42 | MP0002277_abnormal_respiratory_mucosa | 1.15879341 |
| 43 | MP0002928_abnormal_bile_duct | 1.15330357 |
| 44 | MP0001963_abnormal_hearing_physiology | 1.15030293 |
| 45 | MP0010386_abnormal_urinary_bladder | 1.13522793 |
| 46 | MP0005671_abnormal_response_to | 1.13194436 |
| 47 | MP0000026_abnormal_inner_ear | 1.12721257 |
| 48 | MP0005386_behavior/neurological_phenoty | 1.11733280 |
| 49 | MP0004924_abnormal_behavior | 1.11733280 |
| 50 | MP0005075_abnormal_melanosome_morpholog | 1.11643327 |
| 51 | MP0003635_abnormal_synaptic_transmissio | 1.09910995 |
| 52 | MP0000383_abnormal_hair_follicle | 1.09173337 |
| 53 | MP0002638_abnormal_pupillary_reflex | 1.09070380 |
| 54 | MP0004147_increased_porphyrin_level | 1.08665760 |
| 55 | MP0002572_abnormal_emotion/affect_behav | 1.04435338 |
| 56 | MP0000230_abnormal_systemic_arterial | 1.03527680 |
| 57 | MP0006276_abnormal_autonomic_nervous | 1.02214758 |
| 58 | MP0002733_abnormal_thermal_nociception | 1.01582735 |
| 59 | MP0001970_abnormal_pain_threshold | 1.01352084 |
| 60 | MP0002063_abnormal_learning/memory/cond | 1.00931499 |
| 61 | MP0005195_abnormal_posterior_eye | 1.00914562 |
| 62 | MP0003119_abnormal_digestive_system | 1.00748345 |
| 63 | MP0004133_heterotaxia | 0.99654441 |
| 64 | MP0000372_irregular_coat_pigmentation | 0.98932290 |
| 65 | MP0009764_decreased_sensitivity_to | 0.98133365 |
| 66 | MP0005167_abnormal_blood-brain_barrier | 0.95987025 |
| 67 | MP0003121_genomic_imprinting | 0.94648337 |
| 68 | MP0005083_abnormal_biliary_tract | 0.94447780 |
| 69 | MP0005174_abnormal_tail_pigmentation | 0.94249676 |
| 70 | MP0000681_abnormal_thyroid_gland | 0.90441821 |
| 71 | MP0003880_abnormal_central_pattern | 0.90140525 |
| 72 | MP0001440_abnormal_grooming_behavior | 0.89780516 |
| 73 | MP0004742_abnormal_vestibular_system | 0.88789976 |
| 74 | MP0003011_delayed_dark_adaptation | 0.87392204 |
| 75 | MP0004043_abnormal_pH_regulation | 0.85925155 |
| 76 | MP0003638_abnormal_response/metabolism_ | 0.84824285 |
| 77 | MP0000427_abnormal_hair_cycle | 0.84230670 |
| 78 | MP0004215_abnormal_myocardial_fiber | 0.83766944 |
| 79 | MP0002693_abnormal_pancreas_physiology | 0.82157327 |
| 80 | MP0006082_CNS_inflammation | 0.80227195 |
| 81 | MP0005670_abnormal_white_adipose | 0.78950387 |
| 82 | MP0002557_abnormal_social/conspecific_i | 0.78925611 |
| 83 | MP0002752_abnormal_somatic_nervous | 0.76629634 |
| 84 | MP0002184_abnormal_innervation | 0.73139727 |
| 85 | MP0008875_abnormal_xenobiotic_pharmacok | 0.71608174 |
| 86 | MP0002734_abnormal_mechanical_nocicepti | 0.71399427 |
| 87 | MP0002067_abnormal_sensory_capabilities | 0.70742730 |
| 88 | MP0009053_abnormal_anal_canal | 0.70469798 |
| 89 | MP0001873_stomach_inflammation | 0.70272161 |
| 90 | MP0008775_abnormal_heart_ventricle | 0.70006390 |
| 91 | MP0002095_abnormal_skin_pigmentation | 0.69678717 |
| 92 | MP0002229_neurodegeneration | 0.69377813 |
| 93 | MP0001664_abnormal_digestion | 0.69213585 |
| 94 | MP0003567_abnormal_fetal_cardiomyocyte | 0.68583021 |
| 95 | MP0005360_urolithiasis | 0.67785650 |
| 96 | MP0001800_abnormal_humoral_immune | 0.67194465 |
| 97 | MP0005410_abnormal_fertilization | 0.66601906 |
| 98 | MP0009765_abnormal_xenobiotic_induced | 0.66132447 |
| 99 | MP0002653_abnormal_ependyma_morphology | 0.65230492 |
| 100 | MP0003879_abnormal_hair_cell | 0.65126607 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pancreatic cysts (HP:0001737) | 4.31955941 |
| 2 | Pancreatic fibrosis (HP:0100732) | 3.83212840 |
| 3 | True hermaphroditism (HP:0010459) | 3.68551119 |
| 4 | Stenosis of the external auditory canal (HP:0000402) | 3.66626610 |
| 5 | Congenital stationary night blindness (HP:0007642) | 3.65202868 |
| 6 | Congenital, generalized hypertrichosis (HP:0004540) | 3.59391764 |
| 7 | Hypochromic microcytic anemia (HP:0004840) | 3.45112863 |
| 8 | Nephronophthisis (HP:0000090) | 3.39042186 |
| 9 | Abnormality of the renal collecting system (HP:0004742) | 3.29312659 |
| 10 | Abolished electroretinogram (ERG) (HP:0000550) | 3.28238951 |
| 11 | Abnormality of the renal cortex (HP:0011035) | 3.25832260 |
| 12 | Pendular nystagmus (HP:0012043) | 3.19384455 |
| 13 | Congenital sensorineural hearing impairment (HP:0008527) | 3.16696743 |
| 14 | Genetic anticipation (HP:0003743) | 3.13404405 |
| 15 | Morphological abnormality of the middle ear (HP:0008609) | 3.07949033 |
| 16 | Molar tooth sign on MRI (HP:0002419) | 3.07813824 |
| 17 | Abnormality of midbrain morphology (HP:0002418) | 3.07813824 |
| 18 | Abnormality of the renal medulla (HP:0100957) | 3.06843156 |
| 19 | Hyperventilation (HP:0002883) | 3.00644215 |
| 20 | Protruding tongue (HP:0010808) | 2.97363519 |
| 21 | Tented upper lip vermilion (HP:0010804) | 2.96243410 |
| 22 | Abnormality of the nasal septum (HP:0000419) | 2.94743781 |
| 23 | Keratoconus (HP:0000563) | 2.86466069 |
| 24 | Increased corneal curvature (HP:0100692) | 2.86466069 |
| 25 | Methylmalonic acidemia (HP:0002912) | 2.86347839 |
| 26 | Progressive cerebellar ataxia (HP:0002073) | 2.79245422 |
| 27 | Volvulus (HP:0002580) | 2.71150976 |
| 28 | Attenuation of retinal blood vessels (HP:0007843) | 2.69110738 |
| 29 | Cystic liver disease (HP:0006706) | 2.59215779 |
| 30 | Abnormality of cochlea (HP:0000375) | 2.57786060 |
| 31 | Gaze-evoked nystagmus (HP:0000640) | 2.55834317 |
| 32 | Methylmalonic aciduria (HP:0012120) | 2.51629894 |
| 33 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.42479784 |
| 34 | Type II lissencephaly (HP:0007260) | 2.42228701 |
| 35 | Short 1st metacarpal (HP:0010034) | 2.41974724 |
| 36 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.41974724 |
| 37 | Renal cortical cysts (HP:0000803) | 2.39644455 |
| 38 | Male pseudohermaphroditism (HP:0000037) | 2.38743953 |
| 39 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.38092066 |
| 40 | Stomatitis (HP:0010280) | 2.36332379 |
| 41 | Tubular atrophy (HP:0000092) | 2.28310079 |
| 42 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.27638110 |
| 43 | Decreased central vision (HP:0007663) | 2.26125680 |
| 44 | Chorioretinal atrophy (HP:0000533) | 2.24932115 |
| 45 | Medial flaring of the eyebrow (HP:0010747) | 2.23577418 |
| 46 | Sclerocornea (HP:0000647) | 2.23257126 |
| 47 | Morphological abnormality of the inner ear (HP:0011390) | 2.19601048 |
| 48 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.14000661 |
| 49 | Abnormality of alanine metabolism (HP:0010916) | 2.14000661 |
| 50 | Hyperalaninemia (HP:0003348) | 2.14000661 |
| 51 | Abnormality of the 1st metacarpal (HP:0010009) | 2.08639486 |
| 52 | Goiter (HP:0000853) | 2.07507941 |
| 53 | Stomach cancer (HP:0012126) | 2.06720692 |
| 54 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.06398529 |
| 55 | Limb hypertonia (HP:0002509) | 2.05877835 |
| 56 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.05504466 |
| 57 | Focal seizures (HP:0007359) | 2.03666753 |
| 58 | Furrowed tongue (HP:0000221) | 1.99917616 |
| 59 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.99755525 |
| 60 | Abnormal drinking behavior (HP:0030082) | 1.99084183 |
| 61 | Polydipsia (HP:0001959) | 1.99084183 |
| 62 | Asplenia (HP:0001746) | 1.97824095 |
| 63 | Clumsiness (HP:0002312) | 1.96845579 |
| 64 | Optic nerve hypoplasia (HP:0000609) | 1.96658119 |
| 65 | Small hand (HP:0200055) | 1.95344982 |
| 66 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.93495749 |
| 67 | Hyperglycinemia (HP:0002154) | 1.92802873 |
| 68 | Thyroid-stimulating hormone excess (HP:0002925) | 1.91514091 |
| 69 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.90638820 |
| 70 | Broad-based gait (HP:0002136) | 1.90491475 |
| 71 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.89781361 |
| 72 | Drooling (HP:0002307) | 1.89174763 |
| 73 | Abnormality of the frontal sinuses (HP:0002687) | 1.87151705 |
| 74 | Agitation (HP:0000713) | 1.86691693 |
| 75 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.86077510 |
| 76 | Inability to walk (HP:0002540) | 1.85968400 |
| 77 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.85758619 |
| 78 | Prostate neoplasm (HP:0100787) | 1.84903013 |
| 79 | Lip pit (HP:0100267) | 1.84874074 |
| 80 | Absent speech (HP:0001344) | 1.84817803 |
| 81 | Congenital hepatic fibrosis (HP:0002612) | 1.83605393 |
| 82 | Febrile seizures (HP:0002373) | 1.83046972 |
| 83 | Hemiparesis (HP:0001269) | 1.82985504 |
| 84 | Short hallux (HP:0010109) | 1.82391943 |
| 85 | Short tibia (HP:0005736) | 1.81991333 |
| 86 | Hypoproteinemia (HP:0003075) | 1.81555963 |
| 87 | Decreased circulating renin level (HP:0003351) | 1.77584773 |
| 88 | Submucous cleft hard palate (HP:0000176) | 1.76953119 |
| 89 | Excessive salivation (HP:0003781) | 1.76018205 |
| 90 | Chronic hepatic failure (HP:0100626) | 1.75964315 |
| 91 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 1.75195625 |
| 92 | Anencephaly (HP:0002323) | 1.74475859 |
| 93 | Shawl scrotum (HP:0000049) | 1.73088900 |
| 94 | Dyskinesia (HP:0100660) | 1.72434177 |
| 95 | Progressive inability to walk (HP:0002505) | 1.71960683 |
| 96 | Abnormality of the incisor (HP:0000676) | 1.71778069 |
| 97 | Ketosis (HP:0001946) | 1.71695223 |
| 98 | Thyroiditis (HP:0100646) | 1.71287697 |
| 99 | Absent/shortened dynein arms (HP:0200106) | 1.69919041 |
| 100 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.69919041 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 6.47063724 |
| 2 | GRK1 | 3.20330414 |
| 3 | TAOK3 | 3.19821678 |
| 4 | ADRBK2 | 3.12987062 |
| 5 | MAP4K2 | 2.95024165 |
| 6 | BMPR1B | 2.61002987 |
| 7 | PINK1 | 2.51836498 |
| 8 | MAPK13 | 2.39316605 |
| 9 | ACVR1B | 2.17212050 |
| 10 | INSRR | 2.14891961 |
| 11 | NUAK1 | 1.97559751 |
| 12 | TXK | 1.95272867 |
| 13 | WNK3 | 1.93865009 |
| 14 | CASK | 1.78429365 |
| 15 | ZAK | 1.63925868 |
| 16 | DAPK2 | 1.57591506 |
| 17 | TLK1 | 1.43196933 |
| 18 | OXSR1 | 1.40041231 |
| 19 | MAP3K4 | 1.28716288 |
| 20 | STK39 | 1.27767095 |
| 21 | KIT | 1.19519641 |
| 22 | EPHA3 | 1.18255940 |
| 23 | MARK1 | 1.14397358 |
| 24 | PLK2 | 1.11110635 |
| 25 | ADRBK1 | 1.10234023 |
| 26 | NTRK3 | 1.09330761 |
| 27 | STK38L | 1.08581479 |
| 28 | SGK2 | 1.05242309 |
| 29 | WNK4 | 1.04919684 |
| 30 | TNK2 | 1.01735433 |
| 31 | IKBKB | 1.00843335 |
| 32 | NTRK2 | 1.00500907 |
| 33 | TEC | 0.96443173 |
| 34 | GRK7 | 0.94308948 |
| 35 | PAK3 | 0.93570624 |
| 36 | PRKCE | 0.92501719 |
| 37 | BCKDK | 0.91020294 |
| 38 | TIE1 | 0.89005814 |
| 39 | CAMKK2 | 0.86495932 |
| 40 | PTK2B | 0.81559485 |
| 41 | CSNK1G2 | 0.79621125 |
| 42 | FLT3 | 0.78302457 |
| 43 | MUSK | 0.75998196 |
| 44 | PRKCG | 0.73543923 |
| 45 | SYK | 0.71126020 |
| 46 | MAP2K7 | 0.69361599 |
| 47 | PIK3CG | 0.68563083 |
| 48 | CSNK1G1 | 0.68058651 |
| 49 | MAP2K6 | 0.67904087 |
| 50 | FES | 0.67455092 |
| 51 | SGK494 | 0.67441049 |
| 52 | SGK223 | 0.67441049 |
| 53 | MKNK2 | 0.67355681 |
| 54 | ITK | 0.67063241 |
| 55 | MAPKAPK3 | 0.66596142 |
| 56 | CSNK1G3 | 0.66473241 |
| 57 | PRKD2 | 0.64730095 |
| 58 | TNIK | 0.63614534 |
| 59 | CSNK1A1L | 0.62920501 |
| 60 | PRKCQ | 0.62794457 |
| 61 | SIK2 | 0.62760206 |
| 62 | TRIM28 | 0.62367127 |
| 63 | DYRK2 | 0.62264992 |
| 64 | PKN1 | 0.61174066 |
| 65 | CAMK2A | 0.60757601 |
| 66 | ERBB3 | 0.58701290 |
| 67 | IKBKE | 0.56619221 |
| 68 | LYN | 0.56437232 |
| 69 | PIK3CA | 0.56195368 |
| 70 | RPS6KA5 | 0.54929197 |
| 71 | TGFBR1 | 0.54912713 |
| 72 | STK11 | 0.54854325 |
| 73 | GRK5 | 0.52919192 |
| 74 | PRKACA | 0.51616090 |
| 75 | ABL1 | 0.49529453 |
| 76 | CHUK | 0.49405507 |
| 77 | LCK | 0.49374953 |
| 78 | STK3 | 0.48947370 |
| 79 | CSNK1A1 | 0.47411475 |
| 80 | AKT3 | 0.46825150 |
| 81 | GRK6 | 0.46487378 |
| 82 | OBSCN | 0.46428989 |
| 83 | BTK | 0.45582720 |
| 84 | CAMK4 | 0.45465918 |
| 85 | BCR | 0.45275448 |
| 86 | VRK1 | 0.44643036 |
| 87 | HCK | 0.42722702 |
| 88 | PHKG2 | 0.42121514 |
| 89 | PHKG1 | 0.42121514 |
| 90 | FER | 0.40617174 |
| 91 | ERBB2 | 0.40416530 |
| 92 | PIM1 | 0.39383951 |
| 93 | MARK3 | 0.39221766 |
| 94 | MAP3K7 | 0.39142301 |
| 95 | RPS6KA6 | 0.38988899 |
| 96 | NLK | 0.38452348 |
| 97 | IGF1R | 0.36982582 |
| 98 | PRKCA | 0.36932522 |
| 99 | SGK1 | 0.36710652 |
| 100 | MAPKAPK5 | 0.36052660 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 2.71496148 |
| 2 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.64384795 |
| 3 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.63527745 |
| 4 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.51054013 |
| 5 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.43725510 |
| 6 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.40465266 |
| 7 | Nicotine addiction_Homo sapiens_hsa05033 | 2.38214662 |
| 8 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.29412078 |
| 9 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.19445781 |
| 10 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.09157621 |
| 11 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.94146075 |
| 12 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.92351006 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.90657259 |
| 14 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.87926527 |
| 15 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.85085308 |
| 16 | Morphine addiction_Homo sapiens_hsa05032 | 1.70624491 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.66231112 |
| 18 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.59720462 |
| 19 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.48305437 |
| 20 | Taste transduction_Homo sapiens_hsa04742 | 1.47307682 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.47167022 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.46278764 |
| 23 | Asthma_Homo sapiens_hsa05310 | 1.44190485 |
| 24 | Homologous recombination_Homo sapiens_hsa03440 | 1.36603414 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.31434863 |
| 26 | Circadian entrainment_Homo sapiens_hsa04713 | 1.30712035 |
| 27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.30402088 |
| 28 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.28993984 |
| 29 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.26698059 |
| 30 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.25973524 |
| 31 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.25323470 |
| 32 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.25075020 |
| 33 | Olfactory transduction_Homo sapiens_hsa04740 | 1.24125435 |
| 34 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.18755945 |
| 35 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.15611272 |
| 36 | GABAergic synapse_Homo sapiens_hsa04727 | 1.15289981 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.14224122 |
| 38 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.13519578 |
| 39 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.12566273 |
| 40 | Retinol metabolism_Homo sapiens_hsa00830 | 1.11421008 |
| 41 | Salivary secretion_Homo sapiens_hsa04970 | 1.10848355 |
| 42 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.10267067 |
| 43 | Insulin secretion_Homo sapiens_hsa04911 | 1.09606463 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.09563094 |
| 45 | Allograft rejection_Homo sapiens_hsa05330 | 1.07780225 |
| 46 | Protein export_Homo sapiens_hsa03060 | 1.03851336 |
| 47 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.01331318 |
| 48 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.99716560 |
| 49 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.98993503 |
| 50 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.97505276 |
| 51 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.96862676 |
| 52 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.96761483 |
| 53 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.93591050 |
| 54 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.93472994 |
| 55 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.93316974 |
| 56 | RNA degradation_Homo sapiens_hsa03018 | 0.90083146 |
| 57 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.89815956 |
| 58 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.85343927 |
| 59 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.84380257 |
| 60 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.84152194 |
| 61 | Basal transcription factors_Homo sapiens_hsa03022 | 0.83059214 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.78944441 |
| 63 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.77097688 |
| 64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.76160288 |
| 65 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.73831618 |
| 66 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.72947730 |
| 67 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.72696096 |
| 68 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.70600011 |
| 69 | Renin secretion_Homo sapiens_hsa04924 | 0.68088274 |
| 70 | Peroxisome_Homo sapiens_hsa04146 | 0.66934566 |
| 71 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.65687668 |
| 72 | RNA polymerase_Homo sapiens_hsa03020 | 0.64265721 |
| 73 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.64220615 |
| 74 | Long-term depression_Homo sapiens_hsa04730 | 0.63760467 |
| 75 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.61200441 |
| 76 | Histidine metabolism_Homo sapiens_hsa00340 | 0.59481141 |
| 77 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.58087081 |
| 78 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.57898187 |
| 79 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.56198918 |
| 80 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.55198544 |
| 81 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55186280 |
| 82 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.54370067 |
| 83 | Parkinsons disease_Homo sapiens_hsa05012 | 0.53617851 |
| 84 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.52294345 |
| 85 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.50396322 |
| 86 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.49338481 |
| 87 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.48457113 |
| 88 | Melanoma_Homo sapiens_hsa05218 | 0.47618067 |
| 89 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45918904 |
| 90 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.45357338 |
| 91 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.42416490 |
| 92 | Alzheimers disease_Homo sapiens_hsa05010 | 0.41904484 |
| 93 | Mineral absorption_Homo sapiens_hsa04978 | 0.40752301 |
| 94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.40428062 |
| 95 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.40108226 |
| 96 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.39784523 |
| 97 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.39655213 |
| 98 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.39124213 |
| 99 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.38114855 |
| 100 | Cocaine addiction_Homo sapiens_hsa05030 | 0.37462446 |

